NO305931B1 - Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler - Google Patents

Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler

Info

Publication number
NO305931B1
NO305931B1 NO931832A NO931832A NO305931B1 NO 305931 B1 NO305931 B1 NO 305931B1 NO 931832 A NO931832 A NO 931832A NO 931832 A NO931832 A NO 931832A NO 305931 B1 NO305931 B1 NO 305931B1
Authority
NO
Norway
Prior art keywords
biologically active
active agents
crystalline phase
liquid crystalline
composition
Prior art date
Application number
NO931832A
Other languages
English (en)
Norwegian (no)
Other versions
NO931832D0 (no
NO931832L (no
Inventor
Pia Lading
Yvonne Lundsholm
Tomas Norling
Original Assignee
Dumex Ltd As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dumex Ltd As filed Critical Dumex Ltd As
Publication of NO931832D0 publication Critical patent/NO931832D0/no
Publication of NO931832L publication Critical patent/NO931832L/no
Publication of NO305931B1 publication Critical patent/NO305931B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO931832A 1990-11-21 1993-05-19 Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler NO305931B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002095354A CA2095354C (en) 1990-11-21 1990-11-21 Method and composition for controlled delivery of biologically active agents
PCT/DK1990/000299 WO1992009272A1 (en) 1990-11-21 1990-11-21 Method and composition for controlled delivery of biologically active agents

Publications (3)

Publication Number Publication Date
NO931832D0 NO931832D0 (no) 1993-05-19
NO931832L NO931832L (no) 1993-07-19
NO305931B1 true NO305931B1 (no) 1999-08-23

Family

ID=25676134

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931832A NO305931B1 (no) 1990-11-21 1993-05-19 Fremgangsmåte for fremstilling av en blanding for kontrollert avgivelse av biologisk aktive midler

Country Status (15)

Country Link
US (1) US5143934A (de)
EP (1) EP0558475B1 (de)
JP (1) JPH03135925A (de)
KR (1) KR0180750B1 (de)
AT (1) ATE115402T1 (de)
AU (1) AU647768B2 (de)
CA (1) CA2095354C (de)
DE (1) DE69015212T2 (de)
DK (1) DK0558475T3 (de)
ES (1) ES2065670T3 (de)
FI (1) FI109452B (de)
GR (1) GR3015329T3 (de)
HU (1) HU220216B (de)
NO (1) NO305931B1 (de)
WO (1) WO1992009272A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US5371109A (en) * 1986-07-01 1994-12-06 Drilletten Ab Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5620700A (en) * 1990-10-30 1997-04-15 Alza Corporation Injectable drug delivery system and method
CA2120359C (en) * 1991-10-04 2000-12-26 Tomas Landh Particles, method of preparing said particles and uses thereof
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
US5538954A (en) * 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
ATE220894T1 (de) * 1993-12-29 2002-08-15 Matrix Pharma Zusammensetzung für lokale freigabe von zytostatika
CA2185803C (en) * 1994-03-18 2006-07-11 Edward M. Rudnic Emulsified drug delivery systems
WO1995031956A1 (en) * 1994-05-20 1995-11-30 Novavax, Inc. Antibacterial oil-in-water emulsions
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US5744062A (en) * 1996-08-29 1998-04-28 R.I.T.A. Corporation Balanced emulsifier blends for oil-in-water emulsions
CN1108149C (zh) 1997-03-18 2003-05-14 新时代株式会社 固体微粒形成用组合物
DK0942780T3 (da) 1997-09-09 2003-10-27 Lyotropic Therapeutics Inc Overtrukne partikler, fremgangsmåder til fremstilling deraf og anvendelse deraf
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
GB0001449D0 (en) * 2000-01-21 2000-03-08 Cortendo Ab Compositions
US6423707B1 (en) 2000-08-28 2002-07-23 California Pacific Medical Center Nitroimidazole ester analogues and therapeutic applications
JP2003171301A (ja) * 2001-11-09 2003-06-20 Mahidol Univ 歯周炎治療における補助剤としてのカルメグゲル
WO2004012680A2 (en) * 2002-08-06 2004-02-12 Lyotropic Therapeutics, Inc. Lipid-drug complexes in reversed liquid and liquid crystalline phases
AU2003260736B8 (en) 2002-08-26 2009-04-23 S.L.A. Pharma Ag A pharmaceutical composition
EP1547604A1 (de) * 2002-08-29 2005-06-29 Toray Industries, Inc. MEDIZINISCHE ZUSAMMENSETZUNG ZUR VERABREICHUNG IN DIE PERIODONTTASCHE MIT BISPHOSPHONSûURE-DERIVAT ODER SEINEN SALZEN ALS WIRKSTOFF
DE60233507D1 (de) * 2002-11-01 2009-10-08 Univ Mahidol Gel, einen antimikrobiellen Extrakt enthaltend als Zusatzmittel in der Therapie von Periodontitis
DE10332680A1 (de) * 2003-07-18 2005-02-17 Biomet Deutschland Gmbh Verwendung von antiseptischen Wirkstoffen in PMMA-Knochenzementen
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
AU2004274000B2 (en) 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
WO2006043705A1 (ja) * 2004-10-19 2006-04-27 National Institute Of Advanced Industrial Scienceand Technology Ｉｉ型キュービック液晶組成物
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
AR048742A1 (es) * 2004-12-22 2006-05-24 Gador Sa Sistema de aplicacion de medicamentos intra-oral
US7125954B2 (en) * 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
CA2601064C (en) * 2005-03-18 2012-03-06 Lg Household & Health Care Ltd. Tooth whitener
JP2008540534A (ja) * 2005-05-09 2008-11-20 ドラッグテック コーポレイション 放出調節薬学組成物
US20080219935A1 (en) * 2005-07-08 2008-09-11 Sang-Hoon Kwak Phase Transitive Breath Care Products
CA2635994A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
AU2006332518A1 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Composition and method of use thereof
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
EP2498754B1 (de) * 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonale mesophasen (h ii) und ihre verwendung
SG177354A1 (en) 2009-07-01 2012-02-28 Dexcel Pharma Technologies Ltd Local therapeutic release device
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
US9308213B2 (en) 2010-10-29 2016-04-12 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US9504664B2 (en) 2010-10-29 2016-11-29 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11224659B2 (en) 2010-10-29 2022-01-18 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US10695431B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US9271950B2 (en) 2010-10-29 2016-03-01 Infirst Healthcare Limited Compositions for treating chronic inflammation and inflammatory diseases
US11202831B2 (en) 2010-10-29 2021-12-21 Infirst Healthcare Limited Solid solution compositions and use in cardiovascular disease
US10695432B2 (en) 2010-10-29 2020-06-30 Infirst Healthcare Limited Solid solution compositions and use in severe pain
US9744132B2 (en) 2010-10-29 2017-08-29 Infirst Healthcare Limited Solid solution compositions and use in chronic inflammation
US8895536B2 (en) 2010-10-29 2014-11-25 Infirst Healthcare Ltd. Compositions and methods for treating chronic inflammation and inflammatory diseases
US9737500B2 (en) 2010-10-29 2017-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
US11730709B2 (en) 2010-10-29 2023-08-22 Infirst Healthcare Limited Compositions and methods for treating severe pain
RU2508101C1 (ru) * 2012-10-16 2014-02-27 Открытое акционерное общество "Биосинтез" Мягкая лекарственная форма комбинированного действия для локального лечения заболеваний пародонта
CN105007947B (zh) * 2013-01-14 2019-02-15 因佛斯特医疗有限公司 固溶体组合物及其在心血管疾病中的用途
RU2677346C2 (ru) * 2013-01-14 2019-01-16 ИнФерст Хэлткэр Лимитед Композиции и способы для лечения сильной боли
KR20150129664A (ko) * 2013-02-04 2015-11-20 인퍼스트 헬스케어 리미티드 만성 염증 및 염증성 질병을 치료하기 위한 조성물 및 방법
WO2014175814A1 (en) * 2013-04-26 2014-10-30 Bioglan Ab Composition for use in reducing scab formation and promoting healing
US20220226627A1 (en) * 2021-01-15 2022-07-21 Covidien Lp Surgical stapling device with therapeutic suppository

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2196322A (en) * 1937-12-04 1940-04-09 Squibb & Sons Inc Pharmaceutical
DK116528A (de) * 1966-09-30
US4568535A (en) * 1982-08-06 1986-02-04 Loesche Walter J Composition for periodontal administration
US4698359A (en) * 1982-08-24 1987-10-06 Cilag, Ag Medicated suppository
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
EP1169958A1 (de) * 2000-06-28 2002-01-09 Tege Patents Aktiengesellschaft Kocheinheit für einen Verkaufsautomaten

Also Published As

Publication number Publication date
EP0558475B1 (de) 1994-12-14
KR0180750B1 (ko) 1999-03-20
HU220216B (hu) 2001-11-28
FI109452B (fi) 2002-08-15
FI932278A0 (fi) 1993-05-19
DK0558475T3 (da) 1995-04-24
ATE115402T1 (de) 1994-12-15
GR3015329T3 (en) 1995-06-30
HU9301346D0 (en) 1993-09-28
CA2095354A1 (en) 1992-05-22
NO931832D0 (no) 1993-05-19
ES2065670T3 (es) 1995-02-16
US5143934A (en) 1992-09-01
CA2095354C (en) 2001-10-09
EP0558475A1 (de) 1993-09-08
AU647768B2 (en) 1994-03-31
JPH03135925A (ja) 1991-06-10
AU7049991A (en) 1992-06-25
DE69015212D1 (de) 1995-01-26
HUT75453A (en) 1997-05-28
WO1992009272A1 (en) 1992-06-11
DE69015212T2 (de) 1995-05-04
NO931832L (no) 1993-07-19
FI932278L (fi) 1993-05-19

Similar Documents

Publication Publication Date Title
NO931832D0 (no) Fremgangsmaate og blanding for kontrollert avgivelse av biologisk aktive midler
AR007715A1 (es) Formulacion acuosa estable de un peptido, un metodo para preparar la misma y su uso para tratamiento
CA2127352A1 (en) Pharmaceutical preparation in the form of an effervescent and/or disintegrating tablet or an instant granulate, and process for producing it
DE59902270D1 (de) Feuchtigkeitsaktivierbares therapeutisches system
CA2140545A1 (en) Use of first runnings coconut fatty acid as insect-repellent
EP0133170A3 (de) Verbindung und Zusammensetzung zur therapeutischen oder diagnostischen Anwendung und Verfahren zur therapeutischen Behandlung
DE69427661D1 (de) Glutaraldehydzusammensetzung
NZ299727A (en) Preparation of valproic acid analogues and its use for treatment of epilepsy
JP2004537546A5 (de)
ES2113803A1 (es) Metodo para el tratamiento de plantas.
RU93034455A (ru) Композиция для контролируемой подачи биологически активных агентов, способ контролируемого высвобождения биологически активного агента, способ лечения периодонтальной болезни
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
ES2155048T3 (es) Composicion biologicamente activa.
JPS5290615A (en) Water-soluble solid and aqueous solution of n4-acylcytosine arabinosid e
BG60542B2 (en) Water soluble composition having coccidiostatic effect
RU93032993A (ru) Состав для обработки скважины и/или призабойной зоны пласта и способ обработки скважины и/или призабойной зоны пласта
RU93016862A (ru) Водно-глицериновый комплекс (2,3-диоксипропил)-орто-титана-хлорид
JPS553807A (en) Manufacture of deodorant using organic substance
RU97102947A (ru) Способ лечения диффузного токсического зоба
CA2031825A1 (en) Bath additive and its use
JPS51151383A (en) Process for cultivating excrement- deodorizing bacteria
UA38504A (uk) Кардіопротекторний засіб для лікування гострого інфаркту міокарда, спосіб його отримання та спосіб його застосування
JPS57146708A (en) Novel oral preparation
JPS54154729A (en) Aminobenzoic acid derivative and drug preparation containing the same
JPS5762236A (en) Novel preparation of 4-hydroxy-2-cyclopentenone

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees